M&A Deal Summary

Laborie Medical Technologies Acquires Optilume BPH

On September 6, 2023, Laborie Medical Technologies acquired medical products company Optilume BPH for 600M USD

Acquisition Highlights
  • This is Laborie Medical Technologies’ 14th transaction in the Medical Products sector.
  • This is Laborie Medical Technologies’ largest (disclosed) transaction.
  • This is Laborie Medical Technologies’ 10th transaction in the United States.
  • This is Laborie Medical Technologies’ 2nd transaction in Minnesota.

M&A Deal Summary

Date 2023-09-06
Target Optilume BPH
Sector Medical Products
Buyer(s) Laborie Medical Technologies
Deal Type Add-on Acquisition
Deal Value 600M USD
Advisor(s) Piper Sandler & Co. (Financial)
Koley Jessen PC (Legal)

Target

Optilume BPH

Plymouth, Minnesota, United States
website
Optilume BPH is a medical device company pioneering the application of its Optilume® drug-coated balloon technology for use in interventional urology including treating urethral strictures and benign prostatic hyperplasia (BPH). Optilume BPH was founded in 2015 and is based in Plymouth, Minnesota.

Search 194,004 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Laborie Medical Technologies

Portsmouth, New Hampshire, United States

website


Category Company
Founded 1967
Sector Medical Products
DESCRIPTION

Laborie Medical Technologies is a manufacturer and supplier of pelvic health and gastrointestinal medical equipment and consumables. Since its founding in 1967, Laborie has been committed to delivering innovative, complete solutions that provide better diagnostics and treatment outcomes to patients worldwide. Laborie Medical Technologies was founded in 1967 and is based in Portsmouth, New Hampshire.


DEAL STATS #
Overall 15 of 15
Sector (Medical Products) 14 of 14
Type (Add-on Acquisition) 14 of 14
State (Minnesota) 2 of 2
Country (United States) 10 of 10
Year (2023) 2 of 2
Size (of disclosed) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-14 Novonate

South San Francisco, California, United States

Novonate is a medical device company, that developed LifeBubble after seeing an unserved need in the Neonatal Intensive Care Unit (NICU). Each year in the U.S., more than 200,000 babies require umbilical cord catheters to receive nutrients and medicine1. Novonate was founded in 2017 and is based in South San Francisco, California.

Buy -